BRPI0907512A2 - Regulaçao genética de mecanismo de defesa do hospedeiro por exposição de mucosas a espécies de interferon alfa natural - Google Patents
Regulaçao genética de mecanismo de defesa do hospedeiro por exposição de mucosas a espécies de interferon alfa naturalInfo
- Publication number
- BRPI0907512A2 BRPI0907512A2 BRPI0907512-7A BRPI0907512A BRPI0907512A2 BR PI0907512 A2 BRPI0907512 A2 BR PI0907512A2 BR PI0907512 A BRPI0907512 A BR PI0907512A BR PI0907512 A2 BRPI0907512 A2 BR PI0907512A2
- Authority
- BR
- Brazil
- Prior art keywords
- interferon alpha
- host defense
- defense mechanism
- natural interferon
- genetic regulation
- Prior art date
Links
- 102000006992 Interferon-alpha Human genes 0.000 title 1
- 108010047761 Interferon-alpha Proteins 0.000 title 1
- 230000004034 genetic regulation Effects 0.000 title 1
- 230000009215 host defense mechanism Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2930808P | 2008-02-15 | 2008-02-15 | |
| US5136608P | 2008-05-08 | 2008-05-08 | |
| PCT/US2009/000960 WO2009102497A2 (en) | 2008-02-15 | 2009-02-17 | Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0907512A2 true BRPI0907512A2 (pt) | 2015-07-21 |
Family
ID=40957441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0907512-7A BRPI0907512A2 (pt) | 2008-02-15 | 2009-02-17 | Regulaçao genética de mecanismo de defesa do hospedeiro por exposição de mucosas a espécies de interferon alfa natural |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110044946A1 (pt) |
| EP (1) | EP2252323A4 (pt) |
| JP (1) | JP2011512353A (pt) |
| KR (1) | KR20110002836A (pt) |
| CN (1) | CN101990438A (pt) |
| AU (1) | AU2009215129B2 (pt) |
| BR (1) | BRPI0907512A2 (pt) |
| CA (1) | CA2715294A1 (pt) |
| NZ (1) | NZ587372A (pt) |
| WO (1) | WO2009102497A2 (pt) |
| ZA (1) | ZA201005827B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2539418C1 (ru) * | 2013-10-18 | 2015-01-20 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" | Способ лечения местно-распространенного рака орофарингеальной зоны |
| CN116531491A (zh) * | 2023-07-07 | 2023-08-04 | 北京三元基因药业股份有限公司 | 一种干扰素α1b在制备防治甲型流感病毒感染引发的疾病的药物中的用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5049378A (en) * | 1989-04-24 | 1991-09-17 | Ciba-Geigy Canada Ltd. | Prevention and treatment of porcine haemophilus pneumonia (PHP) |
| BR9709068A (pt) * | 1996-05-09 | 2000-01-11 | Pharma Pacific Pty Ltd | Processo de tratamento. |
| US7041301B1 (en) * | 1997-11-07 | 2006-05-09 | Mayo Foundation For Medical Education And Research | Interferon immunotherapy |
| US20040258663A1 (en) * | 2003-05-08 | 2004-12-23 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of interferon alpha |
| CA2644670A1 (en) * | 2006-03-08 | 2008-05-08 | Hemispherx Biopharma Inc. | Broad spectrum immune and antiviral gene modulation by oral interferon |
-
2009
- 2009-02-17 BR BRPI0907512-7A patent/BRPI0907512A2/pt not_active IP Right Cessation
- 2009-02-17 WO PCT/US2009/000960 patent/WO2009102497A2/en not_active Ceased
- 2009-02-17 EP EP09710023A patent/EP2252323A4/en not_active Withdrawn
- 2009-02-17 KR KR1020107020600A patent/KR20110002836A/ko not_active Withdrawn
- 2009-02-17 CN CN2009801126305A patent/CN101990438A/zh active Pending
- 2009-02-17 AU AU2009215129A patent/AU2009215129B2/en not_active Ceased
- 2009-02-17 US US12/735,753 patent/US20110044946A1/en not_active Abandoned
- 2009-02-17 JP JP2010546794A patent/JP2011512353A/ja not_active Withdrawn
- 2009-02-17 NZ NZ587372A patent/NZ587372A/xx not_active IP Right Cessation
- 2009-02-17 CA CA2715294A patent/CA2715294A1/en not_active Abandoned
-
2010
- 2010-08-16 ZA ZA2010/05827A patent/ZA201005827B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2252323A4 (en) | 2012-01-11 |
| AU2009215129B2 (en) | 2013-07-18 |
| AU2009215129A1 (en) | 2009-08-20 |
| KR20110002836A (ko) | 2011-01-10 |
| WO2009102497A3 (en) | 2009-11-05 |
| US20110044946A1 (en) | 2011-02-24 |
| JP2011512353A (ja) | 2011-04-21 |
| ZA201005827B (en) | 2011-10-26 |
| WO2009102497A2 (en) | 2009-08-20 |
| EP2252323A2 (en) | 2010-11-24 |
| NZ587372A (en) | 2012-11-30 |
| CN101990438A (zh) | 2011-03-23 |
| CA2715294A1 (en) | 2009-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301211I1 (nl) | Olipudase alfa | |
| BRPI1013227A2 (pt) | pró-fármacos transportadores de interferon alfa | |
| BRPI0912023A2 (pt) | tipo de lâmpada led de turbo reto | |
| BRPI0915741A2 (pt) | bomba alternativa operada por flutuador | |
| DK2125010T3 (da) | Behandling af immunsygdom ved mukosal afgivelse af antigener ved anvendelse af genetisk modificeret lactobacillus | |
| PT2455477E (pt) | Plantas resistentes a doenças | |
| BRPI0908968A2 (pt) | Composição enriquecidas com hemicelulase para potencializar a hidrólise de biomassa | |
| DK1996292T3 (da) | Anvendelse af peptider til bekæmpelse af stråleskade | |
| EP2389444A4 (en) | PROCESSING BIOMASS | |
| EP2474663A4 (en) | ABRASIONAL ART LEATHER | |
| EP2257327A4 (en) | FACIAL MASK WITH UNIVERSAL FIT | |
| EP2114534A4 (en) | TRANSPARENT ANTIMICROBIAL FACIAL MASK | |
| BRPI0914326A2 (pt) | método para formar uma corrente de oxigênio quente | |
| EP2471873A4 (en) | ENERGY RAYS HARDENABLE ELASTOMER COMPOSITION | |
| EP2442650A4 (en) | SUBLINGUAL APOMORPHIN | |
| EP2495286A4 (en) | HARDENING COMPOSITION | |
| BR112013009802A2 (pt) | fotoiniciadores polimerizáveis para composições curáveis por leds | |
| PL2074865T3 (pl) | Sposób kontrolowania barwy światła wyjściowego lampy | |
| EP2342298A4 (en) | TRANSPARENT INORGANIC ORGANIC HYBRID MATERIALS OBTAINED BY PROCESSING AN AQUEOUS SOL GEL | |
| FI20080018A0 (fi) | Hissijärjestelmän liikkeenohjaus | |
| FI20095567A0 (fi) | Valonlähteen valmistaminen | |
| DK2117564T3 (da) | Anvendelse af chitosaner til forøgelse af neglevæksthastigheden | |
| BR112012002975A2 (pt) | composição para o controle de pragas | |
| DK3603384T3 (da) | Plante der er restistent over for bremia | |
| BRPI1010295A2 (pt) | aprimoramentos em uma máscara laríngea. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |